A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
Clinical trial NCT03336619 · COMPLETED
Trial details
- NCT number
- NCT03336619
- Sponsor
- Romark Laboratories L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2019-04-17
- Enrollment
- 1030
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.